The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
Deborah Rosenblum of the Department of Defense tells the U.S. China Economic and Security Review Commission that Washington has to reshore critical supply chains.
The U.S. China Economic and Security Review Commission asked panelists to discuss just how powerful, and important, China supply chains have become to the U.S. economy.
The U.S. China Economic and Security Review Commission heard from panelists this week on Washington’s reshoring efforts. Question: Will there be any buyers?
U.S. farmer associations push for more trade deals in Senate hearing on agriculture.
The Republican-led China Task Force held an impromptu meeting Wednesday, where they backed stronger export and capital controls if they win back the House.
The trade deficit fell. But the January-April goods deficit is still another record breaker.
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
